Introduction {#sec1-1}
============

Pituitary tumors are considered the most common intracranial neoplasms in dogs, making up 25% of secondary intracranial neoplasms in middle-aged and geriatric patients (O'Brien and Coates, 2010). However, in people they only account for 10-12% of all intracranial tumors (Oruçkaptan *et al.*, 2000). The classification of these neoplasms is based on their size and in humans there is a 10 mm cut off that differentiates between pituitary micro and macroadenomas, with giant pituitary adenomas having a diameter of 50 mm (Fracassi *et al.*, 2014). In dogs sellar/parasellar pituitary neoplasms typically refer to micro and macroadenomas and the terminology enlarged and non-enlarged has only recently been introduced, considering that even large adenomas can measure less than 10 mm in diameter (Fracassi *et al.*, 2014).

Clinical signs are mainly related to the serial hormonal dysfunction that leads to Pituitary Dependent Hypercortisolism (PDH) and/or the mass effect on the adjacent brain tissues. This is more significant in the case of large neoplasms. The malignancy of a pituitary lesion is reserved in humans for pituitary tumors that show invasiveness towards the adjacent structures and even local or distant metastatic behaviour (Pollard *et al.*, 2010; Kopczak *et al.*, 2014). In veterinary literature there are few reports concerning pituitary adenocarcinomas, especially the chromophobe subtype (Shimada *et al.*, 1996; Sato *et al.*, 2001) and a recent review of 33 cases showed a 6% prevalence of adenocarcinomas, confirmed by imaging results and subsequent histopathology (Pollard *et al.*, 2010). The present report describes clinical, tomographic, and histopathological features of a pituitary chromophobe carcinoma in a dog.

Case Details {#sec1-2}
============

A 9-year-old, male mixed-breed dog was referred for progressive aggressiveness towards its owner. At the clinical examination, the patient presented normothermic, polypnoic (\>50 apm), and tachycardic (\>140 bpm). Neurological evaluation revealed mental depression, normal gait, and normal postural reaction consistent with a forebrain syndrome. Due to the aggressiveness of the patient, a complete neurological examination was not performed. The diagnostic procedure included blood analysis with leukocyte formula, chest x-rays, abdominal ultrasound (with no relevant findings detected), and brain Magnetic Resonance Imaging (MRI). MRI scans were performed with a low field MRI unit (0,2 T) model Vet-MR^®^ (Esaote S.p.A. Genova, Italy) and 4 mm thick T1-weighted pre and post paramagnetic contrast administration, T2-weighted and FLAIR sequences. At the end of the MRI exam, a total body CT scan was carried out employing a 16-slice CT unit model Brightspeed® (General Electric Healthcare, Milan, Italy), with a pitch of 1, a slice thickness of 1.25 mm, 120 kV and 200 mA.

MRI revealed a moderate ventricular asymmetry, discrete left deviation of the *falx cerebri*, enlargement of the third ventricle and the presence of a large (18x20x15 mm) spheroidal mass in the sellar/parasellar region characterized by isointense on T1 weighted images ([Fig. 1a](#F1){ref-type="fig"},[f](#F1){ref-type="fig"}) and increased signal on T2 weighted ([Fig. 1b](#F1){ref-type="fig"},[e](#F1){ref-type="fig"}) and FLAIR ([Fig. 1c](#F1){ref-type="fig"}). In the dorso-lateral portion of the mass, a circular lesion (6 mm diameter) characterized by intense and homogeneous signal hyperintensity on T2 weighted images was detected ([Fig. 1e](#F1){ref-type="fig"}). After gadolinium-based contrast medium was administered intravenously (0.2 ml/kg), the mass showed heterogeneous intense enhancement ([Fig. 1d](#F1){ref-type="fig"}). A pituitary enlarged adenoma/macroadenoma (invasive adenoma/adenocarcinoma) characterized by the presence of a necrotic/cystic lesion was suspected. Craniopharyngioma was also considered and included as a less likely MRI differential diagnosis. At the CT examination, no metastasis was observed in the chest and abdomen. Moreover, no adrenal hyperplasia was detected, confirming the normal blood tests and the non-secreting nature of the pituitary lesion. Due to the invasive nature of the lesion and the aggressive behavior of the patient the owner elected not to pursue further treatment. The animal was euthanized and the brain was fixed in 10% buffered formalin and submitted for histopathology examination, after written informed consent was obtained from the owner. Samples were processed routinely, embedded in paraffin wax, and sections were stained with hematoxylin and eosin. Pituitary gland was completely effaced by a wide, infiltrative, unencapsulated, not well circumscribed, densely cellular neoplasm composed of polygonal cells arranged in nests and packets supported by a fine fibrovascular stroma with numerous small hyperemic vessels ([Fig. 2a](#F2){ref-type="fig"}). Neoplastic cells had variably distinct cell borders, intermediate N/C ratio, moderate amount of eosinophilic cytoplasm occasionally finely granular ([Fig. 2a](#F2){ref-type="fig"},[b](#F2){ref-type="fig"}). Nuclei were round to ovalar, with one or two magenta nucleoli. Mitosis ranged from 0 to 1 per HPF (2 mitosis in 10 HPF). Severe anisokaryosis, anisocytosis and karyomegaly were evident with rare binucleated cells ([Fig. 2b](#F2){ref-type="fig"}). The neoplasm had infiltrative growth throughout the adjacent brain parenchyma, with invasion of the third ventricle. A focal marginal residual area of pituitary parenchyma was evident. The other portion of evaluated brain was characterized by mild gliosis and satellitosis. No other neoplastic cerebral lesions were detected. Histological findings supported the diagnosis of pituitary chromophobe carcinoma.

![Transverse (a,b,c,d) and Sagittal (e,f) MRI images of the brain showing a large spheroideal mass in the sellar/parasellar region. The mass was characterized by isointense signal on T1-weighted images (a) and high signal on T2-weighted (b and e) and FLAIR (c) sequences. A circular lesion hypointense on T1-weighted (f) and hyperintense on T2-weighted images was observed in the dorso-lateral aspect of the mass. After contrast medium administration, the mass showed a heterogeneous intense enhancement. Note the ventricular asimmetry and the moderate deviation of the falx cerebri on the transverse images of the brain (a,b,c,d).](OpenVetJ-6-158-g001){#F1}

![Histological findings of the pituitary gland. (a) Histological examination showed a wide, infiltrative, unencapsulated, not well circumscribed, densely cellular neoplasm composed of polygonal cells arranged in nests and packets supported by a fine fibrovascular stroma with numerous small hyperemic vessels. (b) Details of the neoplastic cells with severe anisokaryosis, anisocytosis and karyomegaly.](OpenVetJ-6-158-g002){#F2}

Discussion {#sec1-3}
==========

Pituitary carcinomas have been rarely observed in old dogs; moreover, cases of pituitary neoplasm with intense cellular pleomorphism and elevate mitotic index in absence of metastatic lesions are extremely rare. These neoplasms can cause serious functional disorders due to the destruction of the pars distalis of the neurohypophysis. Even though different therapeutical approaches have been described in literature, including trans-sphenoidal surgery and adjuvant therapies like radiotherapy (Oruçkaptan *et al.*, 2000; Hanson *et al.*, 2005; Fracassi *et al.*, 2014), little evidence, concerning large pituitary tumors, of surgical outcome have been described in literature. In the present case the owner decided to euthanize the patient and histopathology revealed the infiltrative nature of the neoplasm towards the adjacent brain tissue.

Cranipharyngioma was considered as a less likely MRI differential diagnosis due to the rounded shape of the neoplasm in continuity with the hypophysis and its sellar/parasellar location peculiar for pituitary tumours. In fact craniopharyngiomas have been rarely reported in dogs (Hawkins *et al.*, 1985; Eckersley *et al.*, 1991) and cats (Nagata *et al.*, 2005), with a more suprasellar and pharyngeal localization, sometimes adjacent to the dura (Hawkins *et al.*, 1985).

Due to the absence of clinical findings compatible with hormonal imbalance or hormonal problem the neoplasm was considered a not-hormonally active tumor, and immunohistochemistry for pituitary hormones was therefore not performed.

In case of not-hormonally active neoplasm, the histological finding is the only strictly clarified method to classify the tumor. Previously a similar neoplasm was reported (Hawkins *et al.*, 1985), based only on histological findings.

The images in the paper show severe anisokaryosis and anisocytosis typical of malignant chromophobe neoplasm. Neoplastic cells were polygonal with a small to moderate amount of eosinophilic to faintly-basophilic finely granular cytoplasm and a large, oval nucleus compatible with chromophobic cells.

In humans the distinction between invasive adenoma and pituitary adenocarcinoma is based on the finding of intracranial or systemic metastasis. It is believed that adenocarcinomas originate from malignant transformation of pre-existing adenomas after a variable latency period. In the presented case, despite the absence of systemic and intracranial metastasis, the infiltrating growth pattern and the presence of neoplastic cells that reach and surround the third ventricle, together with the intense cellular pleomorphism support the diagnosis to a rare malignant form of the neoplasm.
